| # | % | |||||
|---|---|---|---|---|---|---|
| 1 | VANGUARD INDEX FDS | 2,979,100 | 319,508,000 | 27.18% | ||
| 2 | OPHTHOTECH CORP COM | 4,910,487 | 228,485,000 | 19.43% | ||
| 3 | VANGUARD INTL EQUITY INDEX F | 2,101,000 | 113,916,000 | 9.69% | ||
| 4 | INOGEN INC COM | 3,549,320 | 113,543,000 | 9.66% | ||
| 5 | NEVRO CORP | 2,194,841 | 105,199,000 | 8.95% | ||
| 6 | ALDER BIOPHARMACEUTICALS INC | 3,201,183 | 92,386,000 | 7.86% | ||
| 7 | Otonomy Inc | 2,175,025 | 76,909,000 | 6.54% | ||
| 8 | FLEXION THERAPEUTICS INC COM | 2,283,131 | 51,416,000 | 4.37% | ||
| 9 | Wright Medical Group Inc | 4,720,065 | 20,296,000 | 1.73% | PRN | |
| 10 | AKEBIA THERAPEUTICS INC | 1,516,387 | 16,847,000 | 1.43% | ||
| 11 | TOKAI PHARMACEUTICALS INC | 1,184,196 | 13,381,000 | 1.14% | ||
| 12 | AERIE PHARMACEUTICALS INC | 419,652 | 13,152,000 | 1.12% | ||
| 13 | TETRAPHASE PHARMACEUTICALS I COM | 231,419 | 8,479,000 | 0.72% | ||
| 14 | XENON PHARMACEUTICALS INC | 127,563 | 2,151,000 | 0.18% | ||
| 15 | Intersect ENT Inc | 0 | 0 | 0.00% |
Portfolio data is normalized using SEC Form 13F filings, including the Original 13F-HR (0000950123-15-006094, filed 2015.05.15).
From 2023-01-03 onward, the SEC requires values to be reported in nearest dollars. Earlier filings reported values in thousands; therefore, positions shown as $0 in older filings may represent actual values between $0–$999.
